|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Immunology and Allergology (Dr. Panzner) Medical Faculty of the Charles University, Plzen, Czech Republic; Pathologie Immuno-allergique Respiratoire INSERM U416 (Drs. Lafitte and Tsicopoulos), Institut Pasteur de Lille, Calmette Hospital, CHR et U de Lille, France; and Meakins-Christie Laboratories (Drs. Hamid and Tulic), McGill University Health Center, Montréal, Quebec, Canada.
Correspondence to: Meri K. Tulic, PhD, Meakins-Christie Laboratories, McGill University, 3626 St. Urbain St, Montreal, Quebec, Canada H2X 2P2; e-mail: meri.tulic{at}mcgill.ca
Study objective: To examine the differences in the inflammatory cell and cytokine profile between patients with chronic bronchitis (CB) with and without airway obstruction compared to control subjects.
Design: We used bronchial biopsy samples from the patients and control subjects and analyzed them for the presence of CD3 T cells, CD68, major basic protein (MBP), elastase, and tryptase, as well as expression of messenger RNA (mRNA) coding for interleukin (IL)-4, IL-5, interferon (IFN)-
, IL-9, eotaxin, and IFN-
inducible protein (IP)-10. The techniques of immunocytochemistry and in situ hybridization were used. Results were expressed as the number of immunoreactive and mRNA-positive cells per field.
Results: Increased number of elastase, CD68, and MBP-positive cells (n = 9, p < 0.01) was demonstrated in both groups of patients with CB compared to control subjects. In patients with CB and obstruction, the number of elastase, CD68, and the number of CD3-positive cells was significantly increased compared to patients with CB without obstruction (n = 9, p < 0.01). IFN-
mRNA expression was increased in both groups of patients with CB compared to control subjects (n = 9, p < 0.01). IL-9 mRNA was significantly increased only in patients with CB and obstruction (n = 9, p < 0.01). Co-localization studies demonstrated > 80% of all IL-9positive cells to be CD3-positive T cells. IP-10 mRNA was significantly increased in both groups of patients with CB compared to control subjects (n = 9, p < 0.01).
Conclusions: These results indicate a differential expression of inflammatory markers and cytokine mRNA in patients with obstructive CB. Increased presence of T lymphocytes and up-regulation of IL-9 and IP-10 mRNA expression in the bronchial biopsy samples may contribute to the airway obstruction in these patients.
Key Words: bronchial biopsies chronic bronchitis COPD cytokines immunocytochemistry inflammation interleukin-9
This article has been cited by other articles:
![]() |
S. Siddiqui, F. Hollins, S. Saha, and C. E. Brightling Inflammatory cell microlocalisation and airway dysfunction: cause and effect? Eur. Respir. J., December 1, 2007; 30(6): 1043 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Edwards, M. W. Johnson, and S. L. Johnston Combination Therapy: Synergistic Suppression of Virus-Induced Chemokines in Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., May 1, 2006; 34(5): 616 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Hamid How can we improve our assessment of inflammation in clinical studies of COPD that use bronchial biopsies? Eur. Respir. J., February 1, 2006; 27(2): 248 - 249. [Full Text] [PDF] |
||||
![]() |
P. J. Barnes Mediators of Chronic Obstructive Pulmonary Disease Pharmacol. Rev., December 1, 2004; 56(4): 515 - 548. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |